Patent · US Active

Implants with controlled drug delivery features and methods of using same

US9603738B2 · kind B2 · utility

37Cited by
47References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2014
Grant dateMar 28, 2017
Priority date
Expiry dateMar 10, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2250/0067
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more, drugs and may also Include structures which allow for treatment of Increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.